Scinovex
article Open AccessTop 1% cited

Metformin and reduced risk of cancer in diabetic patients

BMJ · 2005 · Vol. 330(7503) · pp. 1304–1305
Josie EvansLouise A. DonnellyAlistair Emslie‐SmithDario R. AlessiAndrew D. Morris

Abstract

Voluntary surveillance systems are subject to under-reporting. Figures may underestimate true numbers. Miscategorisation of probable country of infection by presuming the country with the highest prevalence as the likely country of infection will underestimate the number of infections acquired in the United Kingdom, particularly among people originating from countries with high prevalence. New HIV diagnoses do not represent new HIV infections, as diagnosis can occur at any point between infection and death, which in the natural course of infection is typically 10-12 years. Furthermore, surveillance reports do not distinguish between partners infected in high prevalence countries while visiting and partners infected before migrating from those countries.

Metabolism, Diabetes, and CancerPancreatic function and diabetesDiabetes Treatment and ManagementMetforminMedicineCancerDiabetes mellitusInternal medicineOncologyEndocrinology

MeSH terms

AgedDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMetforminNeoplasmsPilot ProjectsRisk FactorsCase-Control Studies
Citations
2,356
FWCI
11.22
field-weighted impact
References
5
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.